Wade M. Andrew 4
4 · AtriCure, Inc. · Filed Dec 30, 2019
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Wade M. Andrew
Vice President, Finance
Transactions
- Exercise/Conversion
Common Stock
2019-12-26$11.20/sh+1,000$11,200→ 145,715 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-12-26−1,000→ 0 totalExercise: $11.20From: 2012-02-09Exp: 2021-02-09→ Common Stock (1,000 underlying) - Sale
Common Stock
2019-12-26$32.00/sh−1,000$32,000→ 144,715 total
Footnotes (3)
- [F1]These shares were exercised pursuant to a 10b5-1 trading plan.
- [F2]These shares were sold pursuant to a 10b5-1 trading plan.
- [F3]This option was granted on February 9, 2011. The option vests and is exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.